Skip to content

Clinical trials

Completed Phase 1/2 Hematologic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 1/2 Status: Completed Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20081
20102
20111
20121
20132
20141
20151
20171
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical2
Seagen Inc.2
Spark Therapeutics, Inc.2
Ariad Pharmaceuticals1
Astex Pharmaceuticals, Inc.1
Constellation Pharmaceuticals1
Fred Hutchinson Cancer Center1
Il-Yang Pharm. Co., Ltd.1
Kiadis Pharma1
Kyowa Kirin Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases18
Genetic Diseases, Inborn6
Hemorrhagic Disorders6
Blood Coagulation Disorders5
Leukemia5
Blood Coagulation Disorders, Inherited4
Bone Marrow Diseases4
Coagulation Protein Disorders4
Hemophilia A4
Myeloproliferative Disorders4

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.